简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-07-09 19:13 SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares
2025-07-09 19:01 Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder Vote
2025-07-09 10:14 Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella
2025-07-09 10:11 Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial
2025-07-09 09:44 Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD
2025-07-08 18:32 Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVAC
2025-07-08 13:04 Lubrizol’s Apinovex™ Polymer Wins CPhI China’s 2025 Pharma Excipient Award
2025-07-08 12:57 CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology
2025-07-07 11:31 Leading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in Place
2025-07-07 11:21 Leading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in Place
2025-07-04 10:50 Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year
2025-07-02 16:06 Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta
2025-07-02 12:57 Cargill Sets a New Global Benchmark for More Sustainable Cocoa Supply Chains
2025-07-01 16:24 Galderma Announces Departure of Its Chief Financial Officer
2025-07-01 09:30 Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1
2025-06-30 15:10 Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers
2025-06-30 12:32 SBC Medical added to membership of Russell 3000® Index
2025-06-30 10:36 SINOVAC Board of Directors Prevails Against Advantech/Prime’s Lawsuit in Hong Kong
2025-06-30 10:24 BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day
2025-06-30 09:55 PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001

Business Wire Weibo

Press Releases

Latest Releases